{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-22-003142","form_type":"8-K","ticker":"DMAC","cik":"0001401040","company_name":"DiaMedica Therapeutics Inc.","filed_at":"2022-02-11T23:59:59+00:00","discovered_at":"2026-05-14T18:04:06.297546+00:00","generated_at":"2026-06-27T08:42:49.162625+00:00","sec_items":["8.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"DiaMedica sets May 18, 2022 for annual meeting; shareholder proposal deadline March 4, 2022","bullets":["Annual general meeting scheduled for May 18, 2022; date changed by more than 30 days from last year.","Proxy materials expected to be printed March 30 and sent to shareholders around April 5, 2022.","Shareholder proposals for inclusion in proxy must be received by March 4, 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-22-003142","json":"https://secwatch.observer/filing/0001437749-22-003142.json","markdown":"https://secwatch.observer/filing/0001437749-22-003142.md","text":"https://secwatch.observer/filing/0001437749-22-003142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922003142/0001437749-22-003142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401040/000143774922003142/dmtp20220211_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T08:42:49.162625+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}